In breast cancer, signaling through key proliferative pathways, like PI3K/ AKT and MEK/ERK is known to induce PD-L1 expression (Crane et al., 2009; Hasan et al., 2011). This evidence concerns the gene MAP2K7 and breast carcinoma.